DAVIS JOHN C. JR 4
4 · Magenta Therapeutics, Inc. · Filed Feb 12, 2020
Insider Transaction Report
Form 4
DAVIS JOHN C. JR
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-10+104,000→ 104,000 totalExercise: $12.28Exp: 2030-02-09→ Common Stock (104,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020.